通用名称SAVELLA 米那普伦盐酸盐片(milnacipran Hcl,Savella)治疗纤维肌痛综合征有效! 虽然对于本品改善纤维肌痛症状的确切机制尚不明确,但一些研究者认为:某些脑部神经递质的异常可能是纤维肌痛的关键所在。本品可能是通过对5-羟色胺与去甲肾上腺素(NE)再摄取的双重抑制(在体外对NE再摄取抑制的选择性更强)来改善纤维肌痛症状。 在美国进行的2项关键性III期临床研究中,共纳入2084例患者,其中1460例患者接受本品治疗,624例患者则使用安慰剂。结果显示:与安慰剂相比,本品(剂量为100mg/天、200mg/天)能同时显著改善疼痛(视觉模拟评分)、患者整体评价(患者对变化的整体印象评分)与生理功能 (Short Form-36 总体生理健康)。预期,本品将于2009年3月上市。 本品的安全性与耐受性良好。最常见的不良反应为恶心。其他常见不良反应包括便秘、潮热、多汗、呕吐、心悸、心率上升、口干与高血压。本品所报道的大多数不良反应为轻微至中等程度。 SAVELLA Generic Name for SAVELLA Milnacipran HCl 12.5mg, 25mg, 50mg, 100mg; tabs. Legal Classification:Rx Pharmacological Class for SAVELLASerotonin and norepinephrine reuptake inhibitor (SNRI). Manufacturer of SAVELLAForest Laboratories and Cypress Bioscience Indications for SAVELLAFibromyalgia. Adult dose for SAVELLAMay take with food. Titrate dose. Day 1: 12.5mg once. Days 2–3: 12.5mg twice daily. Days 4–7: 25mg twice daily. After Day 7: 50mg twice daily (recommended dose); max 100mg twice daily. Severe renal impairment (CrCl 5–29mL/min): maintenance 25mg twice daily; max 50mg twice daily. Withdraw gradually. Children's dosing for SAVELLA<17yrs: not recommended. Contraindications for SAVELLAAllow at least 14 days after MAOI discontinuance before starting milnacipran; allow at least 5 days after discontinuing milnacipran before starting an MAOI. Uncontrolled narrow-angle glaucoma. Warnings/Precautions for SAVELLASubstantial alcohol abuse, chronic liver disease, end stage renal disease: not recommended. Hypertension. Heart disease. Arrhythmias. Monitor BP and heart rate; reduce dose or discontinue if elevated BP persists. Controlled narrow-angle glaucoma. Seizure disorder. Suicidal ideation (monitor). Mania. Severe hepatic dysfunction. Discontinue if liver dysfunction develops. Volume depleted. GU obstruction. Risk of bleeding. Reevaluate periodically. Write Rx for smallest practical amount. Pregnancy (Cat.C; see literature for effects on fetus). Labor & delivery, nursing mothers: not recommended. Interactions for SAVELLASee Contraindications. Concomitant serotonin precursors (eg, tryptophan), serotonergics (eg, triptans, tramadol): not recommended. Avoid IV digoxin (postural hypotension, tachycardia). May potentiate anticoagulants (eg, aspirin, NSAIDs, coumadin). May antagonize certain antihypertensives (eg, clonidine). Serotonin syndrome with SSRIs, SNRIs, lithium, tramadol, triptans (monitor). Caution with other CNS-active drugs or those that can increase BP. Arrhythmias, hypertension with epinephrine, norepinephrine. Adverse Reactions for SAVELLAGI upset, headache, constipation, dizziness, insomnia, hot flush, hyperhidrosis, palpitations, increased heart rate, dry mouth, hypertension; rare: GU effects in men; hyponatremia (esp. in elderly); serotonin syndrome; seizure. How is SAVELLA supplied?Tabs 12.5mg—60; 25mg, 50mg, 100mg—60, 180; Titration Pack (4 week supply)—1 |
当前位置:药品说明书与价格首页 >> 综合药讯 >> 米那普伦盐酸盐片|Savella(Milnacipran Tablets)
米那普伦盐酸盐片|Savella(Milnacipran Tablets)简介:
通用名称SAVELLA 盐酸米那普伦12.5mg,25毫克,50毫克,100毫克;标签。 法律分类: 接收 药理班SAVELLA 羟色胺和去甲肾上腺素再摄取抑制剂(SNRI)。 制造商SAVELLA 森林生物科学实验室和龙柏 适应症SA ... 关键字:米那普伦盐酸盐片|纤维肌痛
责任编辑:admin
|
最新文章更多推荐文章更多热点文章更多
|